Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 219Magnetic Resonance Spectroscopy 196pembrolizumab 195Carboplatin 169Cisplatin 137Biopsy 130Nivolumab 127Paclitaxel 112Cyclophosphamide 109Radiotherapy 104Gemcitabine 103durvalumab 88Dexamethasone 88atezolizumab 75Rituximab 69Radiation 67Lenalidomide 67Pemetrexed 65Doxorubicin 64Bevacizumab 64Docetaxel 61Etoposide 57Ipilimumab 56olaparib 54Fluorouracil 50Prednisone 49Oxaliplatin 49venetoclax 48Taxes 48Radiosurgery 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × IL32 protein, human × 90 days × Clear all
NCT02573896 2026-03-23

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Active not recruiting
13 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡